{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "20473561", "DateCompleted": {"Year": "2011", "Month": "08", "Day": "29"}, "DateRevised": {"Year": "2021", "Month": "10", "Day": "20"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.1007/s10753-010-9221-4"], "Journal": {"ISSN": "1573-2576", "JournalIssue": {"Volume": "34", "Issue": "3", "PubDate": {"Year": "2011", "Month": "Jun"}}, "Title": "Inflammation", "ISOAbbreviation": "Inflammation"}, "ArticleTitle": "Evaluation of the anti-inflammatory and anti-tumor effect of Ipomoea obscura (L) and its mode of action through the inhibition of proinflammatory cytokines, nitric oxide and COX-2.", "Pagination": {"StartPage": "171", "EndPage": "183", "MedlinePgn": "171-83"}, "Abstract": {"AbstractText": ["Ipomoea obscura (L) is a widely used medicinal plant. In this study, we investigated its anti-inflammatory and anti-tumor effect using in vitro and in vivo models. Methanolic extract of I. obsucra (10 mg/kg b.wt) was given interaperitoneally before inducing inflammation (both acute and chronic) and tumor to mice. I. obscura produced significant inhibition of 55.6%, 42%, and 65% in the paw edema of animals induced by carrageenan, dextran, and formalin respectively. The extract was also a potent inhibitor of lipopolysaccharide (LPS)-induced NO, CRP, and proinflammatory cytokine production via gene expression in peritoneal macrophages. TNF-\u03b1 production by macrophage culture treated with LPS was found to be significantly inhibited by I. obscura. The extract was 100% toxic at a concentration of 500 \u00b5g/mL for both Dalton's lymphoma ascites (DLA) and Ehrlich ascites carcinoma (EAC) cells. The extract was also found to inhibit tumor cell proliferation in a dose and time-dependent manner. It could also inhibit solid tumor development in mice induced with DLA cells and increased life span of mice bearing EAC tumor to 83% and 53.8%, respectively. This anti-inflammatory effect of the extract is assumed to result mainly from the inhibition of some key enzymes and mediators involved in the inflammation and/or cell signaling pathways such as iNOS, COX-2, and proinflammatory cytokines. This anti-inflammatory property might be the reason for its anti-tumor effects."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Immunology, Amala Cancer Research Centre, Amala Nagar, Thrissur, Kerala, 680 555, India."}], "Identifier": [], "LastName": "Hamsa", "ForeName": "T P", "Initials": "TP"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kuttan", "ForeName": "Girija", "Initials": "G"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Inflammation", "NlmUniqueID": "7600105", "ISSNLinking": "0360-3997"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Cyclooxygenase 2 Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Cytokines"}, {"RegistryNumber": "0", "NameOfSubstance": "DNA Primers"}, {"RegistryNumber": "0", "NameOfSubstance": "Inflammation Mediators"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "31C4KY9ESH", "NameOfSubstance": "Nitric Oxide"}, {"RegistryNumber": "9007-41-4", "NameOfSubstance": "C-Reactive Protein"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": [], "DescriptorName": "Base Sequence"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "C-Reactive Protein"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Cyclooxygenase 2 Inhibitors"}, {"QualifierName": ["antagonists & inhibitors", "blood", "genetics"], "DescriptorName": "Cytokines"}, {"QualifierName": ["genetics"], "DescriptorName": "DNA Primers"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gene Expression"}, {"QualifierName": [], "DescriptorName": "In Vitro Techniques"}, {"QualifierName": ["blood", "chemically induced", "drug therapy"], "DescriptorName": "Inflammation"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Inflammation Mediators"}, {"QualifierName": ["chemistry"], "DescriptorName": "Ipomoea"}, {"QualifierName": [], "DescriptorName": "Medicine, Ayurvedic"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred BALB C"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neoplasms, Experimental"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Nitric Oxide"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "J Immunol. 1988 Mar 15;140(6):1999-2007", "ArticleIdList": ["3257994"]}, {"Citation": "J Biol Chem. 2001 Aug 24;276(34):32008-15", "ArticleIdList": ["11410599"]}, {"Citation": "Planta Med. 1992 Feb;58(1):19-21", "ArticleIdList": ["1620738"]}, {"Citation": "Biol Pharm Bull. 2004 Dec;27(12):2028-31", "ArticleIdList": ["15577226"]}, {"Citation": "Cancer Res. 1966 Aug;26(8):1787-800", "ArticleIdList": ["4288553"]}, {"Citation": "Cancer Lett. 1995 Jul 20;94(1):79-83", "ArticleIdList": ["7621448"]}, {"Citation": "Proc Soc Exp Biol Med. 1962 Dec;111:544-7", "ArticleIdList": ["14001233"]}, {"Citation": "J Pharmacol Exp Ther. 1969 Mar;166(1):96-103", "ArticleIdList": ["5776026"]}, {"Citation": "Acta Pharmacol Sin. 2004 Apr;25(4):480-4", "ArticleIdList": ["15066217"]}, {"Citation": "Carcinogenesis. 1988 Dec;9(12):2297-304", "ArticleIdList": ["2847879"]}, {"Citation": "Arch Biochem Biophys. 2003 Sep 1;417(1):3-11", "ArticleIdList": ["12921773"]}, {"Citation": "J Nat Med. 2010 Jan;64(1):42-9", "ArticleIdList": ["19830512"]}, {"Citation": "J Exp Med. 1993 Jul 1;178(1):63-72", "ArticleIdList": ["8315395"]}, {"Citation": "Indian J Exp Biol. 2000 Jan;38(1):88-90", "ArticleIdList": ["11233093"]}, {"Citation": "J Ethnopharmacol. 2008 Jun 19;118(1):166-72", "ArticleIdList": ["18486371"]}, {"Citation": "Nat Rev Drug Discov. 2003 Sep;2(9):736-46", "ArticleIdList": ["12951580"]}, {"Citation": "Surv Synth Pathol Res. 1985;4(1):44-68", "ArticleIdList": ["3895348"]}, {"Citation": "J Orthop Res. 2003 Mar;21(2):256-64", "ArticleIdList": ["12568957"]}, {"Citation": "Biochem Pharmacol. 2002 Feb 1;63(3):343-7", "ArticleIdList": ["11853685"]}, {"Citation": "Anal Biochem. 1982 Oct;126(1):131-8", "ArticleIdList": ["7181105"]}, {"Citation": "Science. 1985 Nov 22;230(4728):943-5", "ArticleIdList": ["3933111"]}, {"Citation": "Indian J Exp Biol. 1997 Mar;35(3):236-9", "ArticleIdList": ["9332168"]}, {"Citation": "Cancer Res. 1998 Apr 15;58(8):1723-9", "ArticleIdList": ["9563490"]}, {"Citation": "J Investig Med. 1995 Feb;43(1):58-67", "ArticleIdList": ["7719760"]}, {"Citation": "Pharm Res. 1996 Aug;13(8):1133-44", "ArticleIdList": ["8865302"]}, {"Citation": "Phytochemistry. 2003 Apr;62(8):1257-63", "ArticleIdList": ["12648548"]}, {"Citation": "Cancer Chemother Pharmacol. 1986;17(3):259-63", "ArticleIdList": ["3742711"]}, {"Citation": "Braz J Med Biol Res. 2003 Jan;36(1):105-12", "ArticleIdList": ["12532233"]}, {"Citation": "J Exp Med. 1974 Mar 1;139(3):528-42", "ArticleIdList": ["4591170"]}, {"Citation": "Immunol Lett. 1995 Nov;48(1):59-64", "ArticleIdList": ["8847093"]}, {"Citation": "Lancet. 2001 Feb 17;357(9255):539-45", "ArticleIdList": ["11229684"]}, {"Citation": "J Immunol Methods. 1992 Jul 6;151(1-2):313-5", "ArticleIdList": ["1629621"]}, {"Citation": "Immunopharmacol Immunotoxicol. 2009 Jun;31(2):222-9", "ArticleIdList": ["18798043"]}, {"Citation": "Biochem Pharmacol. 2006 Nov 30;72(11):1605-21", "ArticleIdList": ["16889756"]}, {"Citation": "Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5258-65", "ArticleIdList": ["7777494"]}, {"Citation": "Ann Surg. 1995 Mar;221(3):220-35", "ArticleIdList": ["7717775"]}, {"Citation": "Eur J Pharmacol. 2007 Mar 8;558(1-3):185-93", "ArticleIdList": ["17207792"]}, {"Citation": "Cancer Metastasis Rev. 2006 Sep;25(3):481-91", "ArticleIdList": ["17103050"]}]}], "History": [{"Year": "2010", "Month": "5", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2010", "Month": "5", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2011", "Month": "8", "Day": "30", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["20473561", "10.1007/s10753-010-9221-4"]}}], "PubmedBookArticle": []}